Literature DB >> 9098177

Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer.

C W Heath1, C A Lally, E E Calle, J K McLaughlin, M J Thun.   

Abstract

The authors examined the relation of hypertension, use of diuretics, and use of antihypertensive medications to the risk of fatal renal cell cancer in a prospective cohort study of 998,904 adult Americans followed for 7 years (1982-1989). Analysis included 335 renal cell cancer deaths (123 in women and 212 in men). Cox proportional hazards modeling was used to calculate rate ratios. Increased rate ratios were present for cigarette smoking in men and for elevated body mass index in both sexes. Significantly increased age-matched rate ratios, independent of smoking and body mass index, were present for hypertension, use of diuretics, and use of hypertension medications, but only for women. Multivariate testing confined these risks to hypertensive women who were using hypertension medications alone (rate ratio = 2.2, 95% confidence interval 1.4-3.5) or with diuretics (rate ratio 2.5, 95% confidence interval 1.5-4.3). Risk was not significantly increased for either men or women who had untreated hypertension or who used diuretics alone with or without hypertension. These findings partly support those of earlier studies suggesting that medications related to treatment of hypertension, or the severity of hypertension itself, may contribute to the etiology of renal cell cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098177     DOI: 10.1093/oxfordjournals.aje.a009157

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

1.  Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women.

Authors:  M Aktar Ali; Arslan Akhmedkhanov; Anne Zeleniuch-Jaquotte; Paolo Toniolo; Krystyna Frenkel; Xi Huang
Journal:  Cancer Detect Prev       Date:  2003

Review 2.  Carcinogenicity of antihypertensive therapy.

Authors:  Ehud Grossman; Franz H Messerli; Uri Goldbourt
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 3.  Carcinogenicity of cardiovascular drugs.

Authors:  E Grossman; F H Messerli; U Goldbourt
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

4.  Antihypertensive medication use and risk of renal cell carcinoma.

Authors:  Joanne S Colt; Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Barry I Graubard; Faith Davis; Julie Ruterbusch; Sonja Berndt; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2017-02-21       Impact factor: 2.506

5.  Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Sofia Christakoudi; Artemisia Kakourou; Georgios Markozannes; Ioanna Tzoulaki; Elisabete Weiderpass; Paul Brennan; Marc Gunter; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Anne-Laure Madika; Gianluca Severi; Verena Katzke; Tilman Kühn; Manuela M Bergmann; Heiner Boeing; Anna Karakatsani; Georgia Martimianaki; Paschalis Thriskos; Giovanna Masala; Sabina Sieri; Salvatore Panico; Rosario Tumino; Fulvio Ricceri; Antonio Agudo; Daniel Redondo-Sánchez; Sandra M Colorado-Yohar; Olatz Mokoroa; Olle Melander; Tanja Stocks; Christel Häggström; Sophia Harlid; Bas Bueno-de-Mesquita; Carla H van Gils; Roel C H Vermeulen; Kay-Tee Khaw; Nicholas J Wareham; Tammy Y N Tong; Heinz Freisling; Mattias Johansson; Hannah Lennon; Dagfinn Aune; Elio Riboli; Dimitrios Trichopoulos; Antonia Trichopoulou; Konstantinos K Tsilidis
Journal:  Int J Cancer       Date:  2019-08-20       Impact factor: 7.396

6.  Body size and renal cell cancer incidence in a large US cohort study.

Authors:  Kenneth F Adams; Michael F Leitzmann; Demetrius Albanes; Victor Kipnis; Steven C Moore; Arthur Schatzkin; Wong-Ho Chow
Journal:  Am J Epidemiol       Date:  2008-06-09       Impact factor: 4.897

7.  Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.

Authors:  Won Jin Ho; Michael S Simon; Vedat O Yildiz; James M Shikany; Ikuko Kato; Jennifer L Beebe-Dimmer; Jeremy P Cetnar; Cathryn H Bock
Journal:  Cancer       Date:  2014-10-09       Impact factor: 6.860

8.  Hypertensive nephropathy is associated with an increased risk of myeloma, skin, and renal cancer.

Authors:  James Goya Heaf; Alastair Hansen; Gunnar Hellmund Laier
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

Review 9.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

10.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.